Filed: 2026-04-24 AccNo: 0001140361-26-016684 Size: 4 MB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
NS
Article DetailSEC EDGAR Filings
SEC EDGAR Filings
8-K - PDS Biotechnology Corp - 8.01 / 9.01
Filed:
2026-04-15
AccNo:
0001140361-26-014693
Size:
526 KB
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits
发布时间04/15 12:55 UTC
首次发现04/15 12:57 UTC
热度104.1
重要度52
情绪0.00
站内整理正文
优先显示结构化正文；如果正文还未抽出，则回退到摘要。
sec_edgar_index_v1 · 715 字符
Form 8-K - Current report: SEC Accession No. 0001140361-26-014693
Filing Date: 2026-04-15
Accepted: 2026-04-15 08:55:12
Documents: 13
Period of Report: 2026-04-15
Items: Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
PDS Biotechnology Corp (Filer) CIK : 0001472091 (see all company filings) EIN. : 264231384 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-37568 | Film No.: 26862660 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)
1 | 8-K | ef20070560_8k.htm iXBRL | 8-K
2 | EXHIBIT 99.1 | ef20070560_ex99-1.htm | EX-99.1
6 | image00001.jpg | GRAPHIC | 245715
3 | XBRL TAXONOMY EXTENSION SCHEMA | pdsb-20260415.xsd | EX-101.SCH
同簇相关文章
从当前文章回到同一事件簇里的其他来源或补充材料。
1 篇